Contact me for: Cutting-edge treatment for Crohn’s disease

Dr. Hehenberger is Coronado Biosciences’ Executive Vice President of Scientific Affairs. Prior to this she served as Coronado’s Executive Vice President & Chief Medical Officer, and before that, as Coronado’s Senior Vice President of Scientific Affairs. Dr. Hehenberger has over 12 years of experience in the healthcare industry. Prior to joining Coronado, Dr. Hehenberger was Senior Vice President for Strategic Alliances at the Juvenile Diabetes Research Foundation (JDRF). She was responsible for advancing the JDRF's involvement with scientific, financial, and commercial partners in the diabetes community. Prior to JDRF, Dr. Hehenberger worked at Johnson & Johnson as Vice President of Metabolic Strategy and Business Development. Dr. Hehenberger also has experience in public and private equity, having been a partner in Scandinavian Life Science Venture, a buy-side healthcare equity analyst at Brummer & Partners and Argus Partners, on the senior management team of Eyetech Pharmaceuticals, and earlier in her career as a strategic management consultant at McKinsey & Co. Dr. Hehenberger holds M.D. and Ph.D. degrees from the Karolinska Institute in Stockholm, Sweden. She continued her research as a JDRF post-doctoral fellow at the Joslin Diabetes Center at Harvard Medical School.

RSS Feed: http://ir.coronadobiosciences.com/RSS.aspx?iid=4308955

Expert Articles by Karin Hehenberger, M.D., Ph.D.

Digestive Health

New treatments for Crohn's disease can help you manage the symptoms There are many autoimmune and immune-mediated diseases—including Crohn’s disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, autism and psoriasis—whose symptoms researchers think c...